ICH – Italy

Istituto Clinico Humanitas (ICH)Humanitas logobianco
Via Manzoni 56
20089 Rozzano (MI)

d-LIVER Contact:

Invernizzi_PietroDr. Pietro Invernizzi
Head of the Liver Unit and Center for Autoimmune Liver Diseases
Tel: +39 02 8224 5128
E-mail: pietro.invernizzi(at)humanitas.it
Website: www.humanitas.it


Humanitas is a highly specialised hospital, research and teaching center. Built around centers for the prevention and treatment of cancer, cardiovascular, neurological and orthopedic disease – together with an Ophthalmic Center and a Fertility Center – Humanitas also operates a highly specialised Emergency Department. First Italian hospital quality certified by Joint Commission International, Humanitas is accredited by the National Health-Care System. Humanitas promotes health, prevention and early diagnosis by means of innovative and advanced outpatient health care facilities. Appointed as IRCCS by the Ministry of Health (an accreditation in the Italian system that acknowledges institutions focused on excellence in clinical care and research), Humanitas is a world-famous center of excellence for immune system-related diseases, from cancer to rheumatoid arthritis. Humanitas Research Hospital is the flagship of a hospital group also present in Bergamo, Turin, Catania and Castellanza (Varese).

Key personnel involved

Dr. Pietro Invernizzi is the head of the Liver Unit and Center for Autoimmune Liver Diseases at Humanitas Research Hospital in Rozzano, Italy. His main interest area is related to Liver diseases and specifically autoimmune liver diseases. He’s been involved at the international level in the development of innovative drugs for primary biliary cirrhosis, primary sclerosing cholangitis, steatohepatitis and liver disease viral (hepatitis C and hepatitis B). He participated in the new Italian and European guidelines on diagnosis and treatment of cholestatic liver diseases and autoimmune diseases of the liver, such as primary biliary cirrhosis and primary sclerosing cholangitis. He is currently engaged in several projects of basic research and clinical trials, in collaboration with numerous Italian and foreign centers. His studies are funded by public institutions and private national and foreign companies, including the National Institute of Health (NIH) in the USA. Dr. Invernizzi is a member of national and international scientific societies.